Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NR6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C2orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF441 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
L3MBTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITM2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927365 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TMEM74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLRT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130357 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2H5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUCLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNNC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC23A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on